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SAPALDIA: Methods and participation in the 
cross-sectional part of the Swiss Study 
on Air Pollution and Lung Diseases in Adults 
Chronic obstructive lung diseases 
contribute to morbidity and morta- 
lity in western countries including 
Switzerland in an important way 
and represent a major public health 
issue 1-3. As awareness of environ- 
mental problems in general has 
grown, the role of air pollutants as 
a potential cause of respiratory 
problems has become an important 
issue in the public debate 4,s. 
Though the short and intermediate 
term effects of air pollutants are 
well established through extensive 
investigations 6-9, knowledge of 
population based prevalences of 
chronic obstructive lung diseases 
and bronchial asthma in particular 
is limited 1~ In addition, little is 
known about the relationship of 
chronic lung disease with low to 
moderate levels of long term air 
pollution, particularly in Europe or 
Switzerland ~, 12. 
SAPALDIA is part of the Swiss National Research 
Programme 26A supported by the Swiss National 
Foundation (Grant No 4026-28099) and by 
the Federal Office of Education and Science. 
SAPALDIA Basle is part of the European Respira- 
tory Health Survey. 
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The European Community Respi- 
ratory Health Survey aims at esti- 
mating the prevalence of asthma, 
asthma-like symptoms, and bron- 
chial reactivity and at assessing 
their association with known or 
suspected risk factors 13. Though 
this study has made a major effort 
in standardising methods of measu- 
ring the prevalence of asthma, it 
was beyond the scope of the pro- 
ject to do the same for the methods 
of measuring air pollution. 
SAPALDIA, the Swiss Study on 
Air Pollution and Lung Diseases in 
Adults, focused on the long term 
health effects of low to moderate 
levels of air pollutants as typically 
seen in the different parts of Swit- 
zerland. Being part of the Euro- 
pean Commmunity Respiratory 
Health Survey, the study used the 
same standardisation methods for 
the health assessment techniques. 
SAPALDIA consisted of two 
parts, a cross-sectional study con- 
ducted in 1991 and a follow-up 
study during the two following 
years. This publication presents the 
methods used in the cross-sectional 
study. 
The main aim of the SAPALDIA 
cross-sectional study was to deter- 
mine the prevalence of bronchial 
asthma, chronic bronchitis and al- 
lergic conditions in the adult popu- 
lation of Switzerland and to iden- 
tify and to determine the respective 
importance of potentially influen- 
cing factors, both on the personal 
(smoking habits, allergy status, 
family history, occupation) and 
environmental level (outdoor and 
indoor pollution, aeroallergens, 
climate). 
The main hypothesis was that, after 
taking into account the known risk 
factors, there exists a relationship 
between the level of air pollutants 
in the range observed in the dif- 
ferent parts of Switzerland and the 
health parameters under observa- 
tion. Due to the information avai- 
lable, it was also possible to test 
further hypotheses regarding the 
other factors under observation, 
for example concerning the effects 
of passive smoking on health 14. 
A further aim of the cross-sectional 
study consisted in the identification 
of individuals usceptible to pre- 
sent symptoms during a prolonged 
observation period - so they 
could be included in the SAPAL- 
DIA follow-up study. This sub- 
sequent study - running over a 
period of two years - aimed at 
studying the relationship between 
environmental conditions and res- 
piratory symptoms in susceptible 
persons with asthma, chronic 
bronchitis or elevated bronchial 
reactivity and in control subjects 
selected from the cross-sectional 
study. 
This technical report represents he 
base documentation for the cross- 
sectional study of SAPALDIA. 
Methods 
The sample 
Selection of areas 
The eight areas participating in the 
SAPALDIA project (Table 1) were 
chosen to represent the variety of 
environmental conditions found in 
Switzerland concerning eography, 
climate, degree of urbanisation and 
air pollution. In detail, the selec- 
tion criteria were: 
- Level of air pollution: SO2, NO2, 
Ozone, TSR 
- Meteorological characteristics: 
duration of sunshine, precipita- 
tion, humidity, temperature, fog 
counts. 
- Degree of urbanisation/geogra- 
phy: urban, suburban, rural, high 
altitude/alpine (more than 1500 
metres above see level). 
Table 1 summarises these condi- 
tions: Compared to the other cen- 
tres, the three urban areas are 
showing high mean levels of air 
pollution, one of them in a sunny 
climate south of the Alps (Luga- 
no), the two other ones in more 
pronounced foggy and cloudy 
weather conditions (Basle, Gene- 
va). Aarau represents a urban-sub- 
urban centre with variable levels of 
air pollution and a rather foggy 
climate, Payerne and Wald are two 
rural areas with lower air pollution 
and varying weather conditions. 
Davos and Montana re two alpine 
regions with low air pollution 
levels. 
Selection of subjects 
The SAPALDIA study population 
was based on random population 
samples from the local registries of 
inhabitants. To meet the selection 
criteria, individuals had to be 18 to 
60 years of age by December 1990, 
local residents for at least three 
years, Swiss nationals or foreigners 
with a residence permit. Because of 
language problems, all Turkish 
citizens (in 1991 1.03% of the 
Swiss population 15) were excluded 
from the sample frame. 
In each area separate samples were 
drawn using a random number 
programme, except for Payerne, 
where the subjects were randomly 
drawn by hand, and for a part of 
the Montana sample, where some 
of the foreign residents were not 
recorded in the electronic registry 
system and had to be randomly 
selected by hand as well. Table 2 
shows the total population size of 
the different centres, sometimes 
consisting of several political com- 
munities, the respective sample 
frames and samples. 
Health assessment 
Local SAPALDIA research centres 
For each of the research centres a 
local respiratory physician was re- 
sponsible for the local team. The 
fieldworker team consisted of a 
junior physician and one or more 
paramedical assistants. All me- 
thods applied were strictly stan- 
dardised and the teams were exten- 
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Centre Temperature Sunshine Precipitation SO z NO2 TSP 03 
duration (mmly,) (l~g/m 3) (i~g/m 3) (l~g/m 3) (l~g/m 3) 
(h/y.) annual an nual annual =98 % 
mean mean mean value 
Geneva 39t  m 10.4 
3.2 
Montana 1531 m 5, 7 
1853 744 17 58 53 231 
1784 758 14 5t 45 131. 
26 51 49 244 
12 43 49 153 
7 22 35 163 
4 23 34 162 
1803 914 8 21 ~. 15 ,429 
2305 881 < 4 10 -10 t54 
Table 1. Climate and air pollution characteristics of the eight SAPALDIA centres in 1991. Sunshine duration and 
precipitation values are annual sums, Temperature, S02, NO2, and TSP (total suspended particles) annual means. 
Ozone is described as the 98th percentile of all measurements (1/2 hour time resolution) of the month with the 
highest values in the year. For each centre the altitude of the main train or bus station is indicated in metres above 
sea level. 
: To ta l  Sample=: SamplE:: 
Tota i  3i 1 
Table 2. Total population, sample frames and sample sizes of the eight 
SAPALDIA centres. 
sively trained before the beginning 
of the data collection period. 
The individuals in the study sample 
were contacted in random order 
throughout 1991 and invited to the 
research centre by the local team. 
Contact was made by mail and if 
necessary also by telephone or 
through personal visits. During 
their visit at the centre, the partici- 
pants were first interviewed by a 
fieldworker using a standardised 
questionnaire, then a blood sample 
was taken, an allergy skin test was 
performed and endexpiratory CO 
and body height were measured 
before the pulmonary function 
testing took place. 
Individuals unwilling to participate 
were asked a number of basic ques- 
tions on sex, age, general health 
and smoking habits by telephone. 
All non-participants also received 
the mailed short questionnaire of 
the European Community Respi- 
ratory Health Survey 13 covering 
sex, age, respiratory health and 
smoking habits. 
As the Basle local research centre 
also took part in the European 
Community Respiratory Health 
Survey, an additional random 
population sample of 5000 inidivi- 
duals (local residents for at least 
3 years, age of 20-44 years) was 
drawn. They all were sent the 
European short questionnaire, and 
out of the individuals reporting 
symptoms 202 participants were 
randomly selected and given the 
full SAPALDIA testing plus spe- 
cific IgE serum tests. All the local 
SAPALDIA participants meeting 
the European age criteria (854 sub- 
jects) were also asked to complete 
the European short questionnaire 
and specific IgE were determined 
in them as well 13. 
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Instruments 
The standardised methods for the 
interview, allergy testing with skin 
and blood tests, lung function and 
bronchial challenge testing were 
developed in coordination with 
the European Community Respi- 
ratory Health Survey ~3. The field- 
workers of the local research teams 
were given detailed instructions in 
several centralised workshops and 
had an intense two month pilot 
period practising the health assess- 
ment techniques under supervision 
before the onset of the study. 
All relevant information concer- 
ning methods and organisation of 
the study was described in form of 
written instructions distributed to 
all local research teams and the 
local responsible respiratory physi- 
cians. During the study the research 
teams were under supervision by 
the local respiratory physician and 
the central epidemiology unit of 
the study. Apart from individual 
contacts four plenary meetings were 
held in 1991 to exchange xperien- 
ces and to improve and maintain 
the methodological standards. 
SALPAD IA questionnaire 
The computerised SAPALDIA 
questionnaire ofthe cross-sectional 
study was developed along with the 
questionnaire of the European 
Community Respiratory Health 
Survey 13. It dealt with the personal 
history of respiratory symptoms, 
family history, occupation, living 
conditions, exposure to animals, 
smoking and general health. In 
comparison to the European ques- 
tionnaire, the SAPALDIA sections 
concerning exposure to tobacco 
smoke, indoor environment and 
occupational exposure were more 
extensive. As the aim of the study 
was not compatible with urine 
collection to validate the respec- 
tive questions, the dietary ques- 
tions of the European question- 
naire were not included. Table 3 
shows the different sections of the 
SAPALDIA questionnaire compar- 
ed to the European questionnaire. 
According to the local languages in
the different centres, three differ- 
ent versions of the questionnaire 
in German, French and Italian were 
used. In order to prevent bias due 
to translation errors and to mini- 
mise bias due to linguistic differ- 
ences, a process of translation and 
cross-translation was applied. First 
a German questionnaire was creat- 
ed, using questions translated from 
the English original of the Euro- 
pean questionnaire. Additional 
questions were created, the socio- 
economic questions were taken 
from the Swiss national census, the 
questions on smoking and passive 
smoking were adopted from the 
MONICA questionnaires. The 
questions in the French and Italian 
versions were translated from the 
German ones, unless they already 
existed in the respective languages 
in the first place. The French and 
Italian questionnaires were subse- 
quently translated into German by 
an independent translator, and the 
three German versions were com- 
pared by a team. In a final step, all 
three versions were translated back 
into English and inconsistencies 
between the original and the re- 
translated questions were explored 
and removed. 
End-expiratory CO 
End-expiratory CO was measured 
with a EC50 Micro-Smokerlizer 
Bedfont. Participants were asked 
to first completely exhale, then 
completely inhale, hold their 
breath for at least 20 seconds and 
finally exhale completely through 
the mouthpiece of the measuring 
device. As alveolar partial pressure 
of CO is correlated to blood levels 
of carboxyhaemoglobin, this was a 
measure of validating the partici- 
pants' answers to smoking habits. 
Pulmonary function testing 
In pulmonary function testing forc- 
ed expiratory manoeuvres were 
performed in order to record the 
forced expiratory volume in one 
second (FEV1), the forced vital 
capacity (FVC) and different expi- 
ratory flow values. The instrument 
used was a Pulmonary Function 
System SensorMedics 2200 SP 
using a mass flow anemometer, dis- 
playing and recording flow-volume 
curves for each trial. The testing 
was performed by a trained field- 
worker according to the recom- 
mendations on standardisation of
spirometry of the American Thor- 
acic Society ATS 16. Three ATS 
acceptability criteria (volume of 
Table 3. Structure of the questionnaires of SAPALDIA and the European 
Community Respiratory Health Survey in comparison. 
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extrapolation less than 5 % FVC or 
less than 100 ml, expiratory time of 
at least 6 seconds, end of test: no 
volume change for the last 2 
seconds of the manoeuvre) were 
displayed and recorded with each 
manoeuvre. The two ATS reprodu- 
cibility criteria (largest two FVC 
and FEV1 values within 5 % of one 
another) were recorded with the 
set of best values and guided the 
technicians decisions for additional 
manoeuvres. At least three and up 
to eight manoeuvres were requir- 
ed, until the 5 criteria described 
were met. 
Each day before spirometry testing 
the spirometer was calibrated with 
a three litre syringe. Tests were per- 
formed to assess between-centre 
and within-centre variability as 
well as variability between devices 
and showed satisfactory results 17. 
All spirometry outputs were visual- 
ly screened by a junior physician 
with experience in lung function 
testing and a qualified respiratory 
physician. 192 flow-volume curves 
in 116 individuals were suggestive 
of coughing or glottis closure and 
were excluded. The spirometry 
technicians also had the option of 
commenting manouvres and their 
critical remarks caused another 40 
exclusions. 
For the analysis of spirometry data, 
the best volume values (FVC, 
FEV1) were chosen from the three 
best manoeuvres recorded for 
each participant. For any values 
to become eligible, the peak flow 
of the corresponding curve could 
not exceed 16 1/sec (higher peak 
flows were the result of erroneous 
recordings due to technical limita- 
tions of the measuring device) and 
the manoeuvre had to pass the 
screening process described above. 
For any FVC to become eligible, 
the ATS-criterion of no volume 
change for the last two seconds of 
the corresponding manoeuvre had 
to be met, and for any FEV1, the 
volume of extrapolation had to be 
less than 5 % of FVC or less than 
100 ml. To be eligible as a best 
volume value, any FVC or FEV1 
had to be within either 5% or 
100 ml of the highest value of FVC 
or FEV1 respectively before any 
exclusions made. 
Best flow values, values of forced 
expiratory time and Tiffeneau 
(FEV1/FVC) were taken from the 
best eligible curve (ranking accor- 
ding to the sum of FVC and FEV1). 
For a complete curve to be eligible, 
both its FVC and FEV1 had to be 
eligible. 
Inhalation tests 
In participants able to produce 
a technically satisfactory spiro- 
metry either bronchial challenge or 
bronchodilatation testing was per- 
formed, conditional on the indivi- 
dual's consent and the fulfilment of 
inclusion criteria. For safety reasons 
a number of exclusion criteria from 
both tests were defined: moyocar- 
dial infarction within the last 3 
months, heart disease under treat- 
ment, epilepsy under treatment, 
pregnancy, lactation, treatment with 
any/3-blockers including exedrops. 
In all participants non-specific 
bronchial reactivity was assessed 
by inhalation challenge with metha- 
choline chloride (Provochlorine| 
unless they had shown bronchial 
obstruction during splrometry. The 
criteria for bronchial obstruction 
were a FEV1/FVC below 80 % or a 
FEV1 below 70 % of the predicted 
values from Quanjer et al. 18. 
After a baseline FEV1 manoeuvre 
following NaC1 inhalation metha- 
choline chloride was administered 
by a Mefar aerosol dosimeter at 
progressing levels up to a cumula- 
tive dose of 2 mg (see Table 4). All 
devices used in the SAPALDIA 
study belonged to the new Mefar 
aerosol dosimeter model develo- 
ped in 1990, producing a constant 
air pressure of 1.7 bar and avoiding 
the problem of pressure falling 
over time encountered in the pre- 
ceding model. The dosimeter was 
automatically triggered at the 
beginning of the inhalation and 
subjects were instructed to hold 
their breath at full inspiration for 
4 seconds. One and two minutes 
after the end of inhalation two 
FEV1 manoeuvres were perform- 
ed and the best of the two man- 
oeuvres was recorded. The test 
was ended either once the cumula- 
tive dose of 2 mg of methacholine 
chloride was reached or after FEV1 
had decreased by 20% or more 
compared to the NaC1 baseline. 
Level Cumulative dose (mg. methacholine) Level status 
1/base 0 standard 
2 0.016 standard 
3 0.031 intermediate 
4 0.063 standard 
5 O. 125 intermediate 
6 0.250 standard 
7 O. 500 intermediate 
8 1 000 standard 
9 2 O00 standard 
Table 4. Inhalation levels during the methacholine bronchial challenge 
testing. If no decrease in FEV1 of 10 % or more compared to the base level 
(NaCI inhalation) was observed, testing proceeded using the standard 
levels only. If a decrease between 10% and 20% occurred, intermediate 
levels were used as well. After a decrease of 20% or more the test was 
stopped. 
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The methacholine chloride solu- 
tion used for bronchial challenge 
testing was supplied for all centres 
by the Pharmacy of the University 
Hospital in Lausanne. 2 samples 
of the solution were sent o the cen- 
tre of the European Community 
Health Survey in London for 
testing in September 1991 and 
March 1992 and were assessed to 
be at 90.1% and 111.63% of the 
reference preparation used by the 
EC Health Survey. 
All nebulisers were tested monthly 
for variation in output, but the cali- 
bration method suggested by the 
European Community Health Sur- 
vey proved to be inappropriate and 
to introduce measurement errors 
of more than 50 %. So all nebuli- 
sers were replaced and recalibrated 
by the manufacturer. In this pro- 
cess, no variance of more than 10 % 
could be detected. Looking at the 
bronchial reactivity data, no hint of 
any differences in the tests per- 
formed before and after the re- 
placement nor of any time trend 
could be found. Therefore if 
any effect of the changing of 
nebulisers existed, it would be 
negligible. 
Study participants with bronchial 
obstruction (FEV1/FVC below 
80 % or a FEV1 below 70 % of the 
predicted values) did not undergo 
bronchial challenge but bronchodi- 
latation testing. They were given 
an inhalation of 200 l~g of salbuta- 
mol, and spirometry was repeated 
after 10 minutes. 
Skin Prick Tests 
Skin prick tests (SPT) were perfor- 
med on the volar forearm using 
Phazet (Pharmacia | allergen coat- 
ed steel ancets, corresponding to a 
prick test extract of 100000 BU 
(biological units)/m119. The inha- 
lant allergens tested for were cho- 
sen according to the known pre- 
valence of specific sensitisation i
Switzerland and in accordance with 
the EC Respiratory Health Survey 
Allergy Testing Protocol: 
- Cat fur 
- Mould (Cladosporium 
herbarum) 
- Timothy grass pollen 
- PeUitory-of-the-Wall pollen 
(Parietaria) 
- House dust mite (Dermato- 
phagoides pteronyssinus) 
- Mould (Alternaria tenuis) 
- Birch pollen 
- Dog epithelia 
- Histamine (positive control) 
- Non-coated lancet (negative 
control) 
Being extremely rare allergens in 
Switzerland, olive and ragweed 
were not included in the selection. 
Dog epithelia were chosen in addi- 
tion to the genuine EC Testing 
Protocol because they were known 
to be important allergens in Swit- 
zerland. 
After degreasing the skin the aller- 
gen-coated 1 mm point of the 
lancet was pressed into the skin 
and removed after one second. 
After 15 minutes the perimeter of 
the swelling was marked by a pen 
and transferred to the data collec- 
tion sheet using transparent tape. 
The widest diameter of the wheal 
was measured, then the largest line 
within the perimeter and perpendi- 
cular to the first diameter was fit- 
ted and used as a second measure. 
In skin prick testing fieldworkers 
repeatedly had to test pairs of 
positive controls (histamine) accor- 
ding to the respective protocol of 
the European Community Health 
Survey to achieve and maintain a
coefficient of variation of less than 
30%. Also the percentage of false 
negative histamine tests was check- 
ed regularly and reinstruction and 
practising sessions were given to 
fieldworkers whenever necessary. 
Several analyses of the SPT data 
were done to compare the field- 
workers within the teams using the 
sum of all adjusted allergen wheal 
diameters and a yes/no variable 
for any reaction to any of the aller- 
gens except histamine. An adjusted 
wheal diameter was defined as the 
mean diameter of a wheal minus 
the mean diameter of the negative 
control in the same individual, 
truncating at zero and therefore 
allowing no negative values. In 
three out of the eight centres diffe- 
rences between technicians turned 
out to be sigificant with respect o 
both variables, in two other centres 
either one or the other variable 
showed a significant variation be- 
tween fieldworkers. 
Serological examinations 
Blood samples were taken from the 
participants and serum was stored 
at -20 ~ before being sent to the 
laboratory for testing. Total serum 
IgE was measured using the Phar- 
macia CAP FEIA system and the 
presence of specific serum IgE 
antibodies to a mixture of relevant 
inhalative allergens (pollen, house 
dust mites, moulds, and animal 
epithelia) was assessed by the 
Phadiatop CAP FEIA test 19,20. 
All serum testing for IgE was done 
in the Allergy Laboratory of the 
Department of Dermatology, Uni- 
versity Hospital Zurich. Extra 
blood samples of two volunteers 
(both consistently Phadiatop osi- 
tive) were distributed in 120 sam- 
ples each and between August and 
December 1991 they were random- 
ly sent o the laboratory with serum 
material from the research centres. 
The repeated measurements of
total IgE were more constant for 
the low atopic individual (109 
usable observations, g = 18.9 kU/1, 
coefficient of variation 13 %) than 
for the highly atopic person (99 
usable observations, 11 = 560.0 kU/1, 
coefficient of varition 22%), and 
for both samples values were 
within the precision claimed by the 
laboratory. 
Env i ronmenta l  Data  
Data available 
Three categories of environmental 
data from different sources were 
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used for the SAPALDIA study: 
Meteorological data, data on air 
pollutants and on pollen. The 
details of the environmental data 
assessment are described in sepa- 
rate publications 21,=. 
All SAPALDIA centres but the 
one in Wald were equipped with an 
automatic meteorological station 
of the monitoring network of the 
Swiss Meteorological Institute in 
Zurich measuring the following 
parameters: 
- Air temperature 
- Atmospheric pressure 
- Vapour pressure 
- Relative humidity 
- Sunshine duration 
- Global radiation 
- Cloudiness 
- Fog observations 
- Precipitation 
- Thunderstorms 
- Wind direction 
- Wind speed 
In Wald air temperature, atmo- 
spheric pressure, vapour pressure, 
relative humidity, wind direction, 
and wind speed were recorded by 
the automatic air pollution monito- 
ring station and sunshine duration 
was measured by a Sunshine Auto- 
graph Fuess. 
For the continuous measurement 
of air pollutants all centres were 
equipped with at least one automa- 
tic monitoring station for sulphur 
dioxide (SO2), nitrogen oxides 
(NOx), nitrogen dioxide (NO2), 
nitrogen monoxide (NO), ozone 
(03) and total suspended particles 
(TSP). Carbon monoxide (CO) 
was measured in all centres but 
Aarau and Payerne. The time re- 
solution was 1 day for TSP and 1/2 
hour for all other pollutants. In 
1992 daily particulate matter of less 
than 10 pm (PM10) measurements 
were introducted in all 8 areas. The 
automatic stations were run by 
local, cantonal or national insti- 
tutions. 
To gain further information on air 
pollution, several additional mea- 
surements were made. From July 
1991 on, in three centres particula- 
tes were sampled by a low-pressure 
impactor to assess size-fractions 
of suspended particles. Geneva, 
Aarau and Davos were chosen to 
represent a city, an urban-suburban 
area on the Swiss plateau and an 
alpine region. 
To obtain more information on the 
local distribution of air pollution 
concentrations, a passive sampling 
network for SO2, NO2 and Ozone 
was installed in all centres. The 
measurements took place simulta- 
neously over a period of four weeks 
in a row giving weekly averages. 
Table 5 gives an overview of the sea- 
sons the passive sampling for the 
different pollutants took place in. 
Passive sampling measurements 
for volatile organic compounds 
(VOC) were carried out for an 
exposure time of two weeks. They 
were measured at one place only 
in each centre simultaneously in 
spring, summer and autumn. 
The term "acid aerosols" is not 
clearly defined and is sometimes 
used for sulphate in particles or sul- 
phuric acid. As in Switzerland the 
concentrations of sulphuric acid 
are usually too low to be detected, 
nitric acid (HNO3), the major com- 
pound responsible for airborne aci- 
dity in Switzerland, was measured 
as well as amonia (NH3) , a possible 
neutralising agent of nitric acid 23. 
Measurements were carried out 
in all centres during the same 
period using a passive sampling 
technique over four consecutive 
weeks in spring, summer and 
autumn. 
Pollen measurements were carried 
out from the end of February until 
the end of Septemer 1991, using the 
Burkard seven days volumetric 
spore trap, a method yielding 
results corresponding to the pollen 
concentration i one cubic metre 
of air per day. The data were ana- 
lysed by aeropallynologists of the 
Swiss working Group for Aero- 
biology. The allergen pollen con- 
sidered in the analyses for all 
centres were: 
- Alder (Alnus sp.) 
- Hazel (Corylus sp.) 
- Birch (Betula sp.) 
- Grass (Gramineae/Poaceae) 
- Mugwort (Artemisia sp.) 
Geneva Bas le  Lugano Aarau Wald Payerne Davos, MOntana 
TSP impa~Or meas. Jul:-Dec JuI-Dec Jul~Dec 
Acid aerosols sptsu/a sptsula sptsu/a sp/sula sp/sula sp/sula splsula sptsu/a 
Table 5. Additional air pollutant measurements in the different centres. Passive sampling was carried out for one 
measurement period in winter (w), spring (sp), summer (su) or autumn (a) depending on the air pollutant. 
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In addition, Chestnut (Castanea 
sp.) and Pellitory-of-the-Wall (Pa- 
rietaria sp.) were considered in 
Lugano only. All pollen of the 
Nettle family (Urticaceae) were 
included in Pellitory-of-the-Wall 
(Parietaria sp.). 
Quality control for continuous 
monitors 
As different authorities and bodies 
were involved in these measure- 
ments, inter-field calibration com- 
parisons were carried out in order 
to assess differences in calibration 
standards and biases in measure- 
ments. The inter-field calibration 
of the monitors was carried out 
by an independent company 
(Oekoscience, Zurich) at all sites. 
In each region, the automated 
reference station was controlled 
for the gaseous compounds NO2, 
NO, SO2, CO, and ozone. 
Before inter-calibration was car- 
ried out, the local authorities cali- 
brated the monitors with their 
own calibration gas. The procedure 
included a check of the monitors 
with zero-gas, passing a mixture of 
NO, NO2 and CO gas through all 
monitors, a sensitivity check of 
NO on the SO2 monitor, a gas- 
phase titration of the conversion 
of NO2 into NO in the NOx moni- 
tor and a check on the ozone 
monitor with an independent ozone 
generator. 
The quality control for 1991 show- 
ed that most monitors were 
measuring within a range of 10 %. 
Only in Geneva and Montana the 
ozone data were overestimated by
more than 20% and by 15% re- 
spectively. 
For TSR an analysis of different 
field inter-comparisons between 
the different monitors (High-Vol- 
Gravimetric, beta radiation and 
tapered oscillation monitor) show- 
ed that there was need for a new 
calibration of the oscillation moni- 
tor used in the second half of 1991 
at Wald. For the others, data were 
within a range of + 15 %. 
Analyses 
Data management 
The local teams ent the data from 
the health assessment excluding 
the serum tests to the epidemiology 
unit of the study at the Institute of 
Social and Preventive Medicine in 
Basle. The serum samples were 
sent to the Allergy Laboratory of 
the Department of Dermatology, 
University Hospital Zurich. There 
analyses were performed and the 
results were sent to the epide- 
miology unit. The environmental 
data was provided by the different 
local facilities and collected and 
controlled by the Institute of 
Hygiene and Applied Physiology 
of the Swiss Federal Institute of 
Technology in Zurich before being 
transferred to the epidemiology 
unit. 
Data were processed at the central 
main frame computer of the "Amt 
fiir Informatik" of the canton of 
Basel-Stadt using the SAS pro- 
gramme. 
Data protection and data security 
Only health data that could not be 
linked to the identity of individuals 
was sent to the epidemiology unit 
of the study in Basle and processed 
there, the names of the participants 
being replaced by identification 
numbers. There were only two pla- 
ces were identification umbers 
and names could be linked: In the 
local research centre under the res- 
ponsibility of the respiratory phy- 
sician, who would give information 
on the health records to the partici- 
pants or their treating physicians, 
and with the study director at the 
Division of Respiratory Medicine 
of the University Hospital in Lau- 
sanne. 
The study data on the central main 
frame computer is only accessible 
to individually authorised mem- 
bers of the research team using 
their individual passwords. The 
local health data of the participants 
(spirometry outputs, allergy test 
results, etc.) is stored and lock- 
ed away the same way as other 
health records under the respon- 
sibility of the local respiratory 
physician. 
Health data results 
This article focuses on the partici- 
pation in the SAPALDIA cross- 
sectional study and on the repre- 
sentativity of the data available. 
The environmental data have been 
presented in separate publica- 
tions21, 22. 
Participation 
Overall participation 
From the original sample of 17311 
a number of 1044 individuals had 
to be excluded, mostly because 
they had moved away (n = 868), in 
some cases because they spend 
most of the week outside the study 
area (n--62), because they had 
died (n = 51), or for a variety of 
other reasons, e.g. being in prison 
(n = 63). Participation, defined as 
having completed at least the 
SAPALDIA questionnaire, was 
achieved for 9651 people, repre- 
senting 59.3 % of the eligible sam- 
ple. In addition, the mailed short 
questionnaire of the European 
Community Respiratory Health 
Survey was obtained from 2244 
persons (13.8%), the telephone 
interview with basic questions on 
sex, age, general health and smok- 
ing habits from another 2234 
(13.7%). 1859 people refused to 
participate inany of the interviews, 
279 could not be contacted, so 
no information was available on 
13.1% of the sample. As table 6 
shows, participation varied sub- 
stantially between the different 
centres, from 41.9% in Geneva to 
74.3 % in Montana. 
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Geneva Basle Lugano Aarau Wald Payerne Davos Montana All centres 
2405 2292 2354 2393 2213 
100% 100% 100% 100% 100% 
Pa~id pation 999 1491 1310 1299 1518 1495 
41.9% 62.0% 57.2% 55.2% 63.4% 67.6% 
EC questionnaire 408 393 391 280 312 235 
17.1% t6.3% 17.1% 11.9% 13.0% 10.6% 
515 275 363 374 t80 301 
21~6% t t .4% 15.8% 15.9% 7.5% 13.6% 
246 228 401 383 182 
10.2% 9.9% 17.0% 16.0% 8.2% 
Telephone 
int~iew 
1154 1069 16267 
100% 100% 100% 
745 794 9651 
64.6% 74.3 % 59.3% 
120 105 2244 
10.4% ,9.8% t3:8% 
165 61 2234 
14.3% 5.7% 13.7% 
124 109 2138 
10 .7% t0.2% t31% 
No information 465 
19.5 % 
Table 6. Overall participation in the study centres of the SAPALDIA cross-sectional study. Participation: at/east 
SAPALDIA questionnaire completed. EC questionnaire: mailed short questionnaire of the European Community 
Repiratory Health Survey completed. Telephone interview: basic questions answered during telephone contact. 
No information: any interview refused or person not reached. 
Participation by test 
All 9651 participants of the study 
completed the computerised ques- 
tionnaire. For the other instru- 
ments participation varied depen- 
ding on the sort of examination 
(Table 7), being generally good for 
endexpiratory CO (99.2%), spiro- 
metry (99.0%), and skin prick 
testing (97.1%). Numbers were 
lower for the serological tests 
requiring the taking of a blood 
sample (89.4 %) and for bronchial 
challenge testing (79.0 %). To 
interpret he small proportion of 
participants having undergone 
bronchial challenge testing and 
bronchodilatation testing, one has 
to bear in mind that only individu- 
als with a spirometry were eligible 
for either of the tests, according to 
the results, and that only the small 
number of participants with bron- 
chial obstruction was supposed to 
undergo bronchodilatation testing. 
Out of the 9552 inidividuals with a 
complete spirometry, 445 showed 
bronchial obstruction (FEV1/FVC 
below 80 % or FEV1 below 70 % of 
the predicted values) and therefore 
did not qualify for bronchial chal- 
lenge testing. Out of the remaining 
9107 participants, 7624 underwent 
bronchial challenge testing, resul- 
ting in 7384 acceptable tests (re- 
presenting 81.1% of the eligible 
individuals). The reasons for not 
having any test results were: exclu- 
sion criteria in the interview (myo- 
cardial infarction within the last 3 
months, heart disease under treat- 
ment, epilepsy under treatment, 
pregnancy, lactation, treatment 
with any /J-blockers including 
eyedrops): 707 (7.8 %); consent for 
testing not given: 445 (4.9 %); other 
reasons (doubts about health status 
of the participant, unsatisfactory 
manoeuvres, technical problems, 
loss of data): 833 (9.1%). More 
than one reason could be given. 
Completeness oftests 
Looking at the completeness of 
tests in individuals, it could be seen 
that 3/4 of the participants had the 
full set of investigations consisting 
of the questionnaire, CO-test, sero- 
logical tests, skin prick tests and 
spirometry with bronchial chal- 
lenge or bronchodilatation testing 
(see Table 8). 81.9 % of all partici- 
pants had complete pulmonary test 
results with spirometry and bron- 
chial challenge or bronchodilata- 
tion testing. 95.3% had complete 
information concerning atopy or 
hyperreactivity with results from 
bronchochallenge testing, serologi- 
cal tests or both. 
The completeness of tests was bet- 
ter in males (79.4% versus 71.4% 
in females). The difference became 
smaller when looking at partici- 
pants with complete pulmonary 
test results (85.0% vs. 79.0%) or 
complete information concerning 
atopy or hyperreactivity (96.2 % vs. 
94.4%). 
Description of participants 
and representativity 
Age 
The age distribution for all partici- 
pants was 19.8% under 30 years of 
age, 38.3 % between 30 and 44 years 
and 41.9% with more than 44 
years. In the different centres these 
proportions were similar, varying 
from 11.3 % to 22.5 % for the youn- 
gest age group, 33.4 % to 47.8 % for 
the intermediate one and 38.3 % to 
47.9 % for the oldest one. 
Comparing the age structure in the 
SAPALDIA participants with the 
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Table 7. Participation in the different tests of the SAPALDIA cross-sectional study. By definition all participants 
had answered the questionnaire. Only individuals with a spirometry were eligible for either bronchodilatation or 
bronchial challenge testing, according to the results of the test. Only the small proportion of participants with 
bronchial obstruction was eligible for bronchodilatation testing. 
Table 8. Completeness of tests in the different centres. A complete set of tests consisted of the questionnaire, 
CO-test, serological tests, skin prick tests and spirometry with bronchial challenge or bronchodilatation testing. 
7907 individuals (81.9 % of all participants) had complete pulmonary test results with spirometry and bronchial 
challenge or bronchodilatation testing. 9197 individuals (95.3%) had complete information concerning atopy 
or hyperreactivity with results from bronchochallenge testing, serological tests or both. 
one in the population of the dif- 
ferent centres by the end of 1991, a 
clear overrepresentation of the 
oldest age group (more than 44 
years of age) and a clear underre- 
presentation of the youngest age 
group (less than 30 years of age) 
could be seen in all centres. This 
comparison might be misleading as 
it was not possible to obtain infor- 
mation on age, sex and nationality 
of all the members of the original 
sample frame meeting the inclu- 
sion criteria. So the population 
consisted of all residents of the stu- 
dy centre areas in the respective 
age groups by the end of December 
1991 without any restriction con- 
cerning the duration of their resi- 
dency. The fact that for 70.3% 
(4652) of the 6616 non-participants 
of the SAPALDIA study informa- 
tion on age was available from 
telephone interviews or short 
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questionnaires made it possible to 
compare their age structure with 
the one found in the SAPALDIA 
participants. The intermediate age 
group (30 to 44 years of age) was 
significantly overrepresented in
the participants (38.3 % of the par- 
ticipants versus 33.3 % of the non- 
participants, p < 0.001 derived from 
X 2 test), while the youngest age 
group (19.8% versus 22.0%) and 
the oldest one were underrepre- 
sented (41.9% vs. 44.7%). This 
pattern varied only little across 
centres. 
Sex 
The SALPADIA participants con- 
sisted of 50.9 % females and 49.1% 
males. This proportion varied only 
little across centres, with the high- 
est differences found in Lugano 
with 55.5% female participants. 
Also considering the sex distribu- 
tion in the different age groups, 
there was only limited variation. 
The proportion of females was 
47.4 % in the youngest age group, 
52.9% in the intermediate one, and 
50.7 % in the oldest one. This find- 
ing is corresponding to a signifi- 
cantly larger intermediate age 
group in the female participants 
(39.9% versus 36.8% of all male 
participants in the same age 
group, p<0.001 derived from X 2 
test), a smaller youngest age group 
(18.5% vs. 21.2%) and a practi- 
cally identical oldest one (41.7% 
vs. 42.0 %). 
Comparing the proportion of 
women in the participants to the 
proportion in the population of the 
study centre areas (in the respec- 
tive age groups by the end of 
December 1991 disregarding the 
SAPALDIA inclusion criteria) and 
in the non-participants, no signifi- 
cant difference was found (50.9 % 
in the participants, 51.0% in the 
population, 51.1% in non-partici- 
pants, information available for 
99.3 % of non-participants, p = 0.81 
from X z test comparing participants 
and population, p = 0.72 compar- 
ing participants and non-partici- 
pants). The same picture was seen 
in all centres with differences of 
less than 3 % between the three dif- 
ferent groups. Only for Basle it was 
possible to obtain information on 
the sex distribution of the local 
population in the respective age 
group who had been residents for 
at least three years by the end of 
1991, but no significant difference 
could be observed here either 
(50.7% females in participants 
versus 50.8% in the local 3 year 
residents, p = 0.96 derived from X 2 
test). 
Nationality 
The overall percentage of non- 
Swiss participants was 18.1%, rang- 
ing from 33.1% in Lugano to 
9.2% in Wald. This proportion 
was very similar in the three age 
groups (16.0% in the youngest 
group; 18.5% in the intermediate 
one, 18.8% in the oldest one; n= 
9638). 
The proportion of individuals with 
non-Swiss nationality was signifi- 
cantly lower in the participants 
(18.1%, n = 9638) than in the popu- 
lation of the study centre areas in 
the respective age groups (32.7 %, 
n = 272328, p < 0.001 derived from 
X 2 test). The respective proportions 
varied widely between centres, but 
were consistently lower in parti- 
cipants than in the population. 
However this comparison does not 
take into account he fact that all 
SAPALDIA participants had to be 
local residents for at least 3 years. 
The respective data was available 
only for Basle, and here it could 
be clearly seen that the proportion 
of foreigners was lower in the par- 
ticipants (18.2%, n = 1487) than in 
the 3 year residents of the same 
age group (21.5 %, n = 95627), but 
the difference was smaller than 
compared to the whole popula- 
tion without restriction on the 
length of residency (24.4%, n= 
115075). 
Smoking 
Out of the 4734 male participants 
who had answered the respective 
questions, 35.8 % were people who 
had never smoked regularly in their 
life (never-smokers), 25.7% were 
people who had stopped smoking 
(ex-smokers) and 38.5% were 
regular smokers. For the 4902 
female participants who had ans- 
wered the questions, the respective 
proportions were 51.7% never- 
smokers, 19.5% ex-smokers and 
28.8% current smokers. 
For 74.0 % of the non-participants 
information was available from the 
telephone interview, whether they 
had ever smoked for at least one 
year. The proportion of never- 
smokers was 58.2% in female 
(n = 2271) and 41.3 % in male non- 
participants (n= 1963). For 31.1% 
of the non-participants informa- 
tion was available from the mailed 
short questionnaire, where the 
question had been asked "are you a 
smoker, ex-smoker or non-smo- 
ker?" The respective proportions 
were 28.7%, 13.5% and 57.8% in 
female non-participants (n = 1132) 
and 36.8%, 17.5% and 45.7% in 
male non-participants (n=914). 
Comparing the proportion of non- 
smokers in these groups to the 
never-smokers a  derived from the 
telephone interview, the propor- 
tion was slightly smaller in the 
female non-participants with a 
mailed questionnaire (p = 0.81 
derived from X 2 test) and signifi- 
cantly higher in the male non-parti- 
cipants with a mailed questionnaire 
(p = 0.02). 
Comparing the smoking status of 
participants to the one of non- 
participants with a telephone inter- 
view, the proportion of never- 
smokers was significantly ower in 
both female (51.7% versus 58.2% 
in non-participants, p<0.001) and 
male participants (35.8% versus 
41.3 %, p < 0.001). 
Comparing the participants o the 
non-participants with a mailed 
short questionnaire, the propor- 
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tions of current smokers were prac- 
tically identical for both genders 
(28.8% versus 28.7% in females, 
38.5 % versus 36.8 % in males). The 
proportion of ex-smokers was 
significantly higher in both female 
(19.5% versus 13.5 % in non-parti- 
cipants, p< 0.001) and male (25.7 % 
versus 17.5 %, p < 0.001) partici- 
pants, therefore reducing the 
proportion of never-smokers in 
participants (51.7 % versus 57.8 % 
in female non-participants, 35.8% 
versus 45.7 % in males). 
However there are indications of a 
possibly important misclassifica- 
tion error due to a misunderstand- 
ing of the question in the mailed 
short questionnaire "are you a smo- 
ker, ex-smoker or non-smoker?" A 
number of participants of the 
SAPALDIA study had also receiv- 
ed the mailed short questionnaire 
and answered the question on 
smoking (n = 195) and so it was 
possible to validate these answers 
against he stepwise deduction of 
smoking status in the computerised 
interview ("have you ever smoked 
for as long as a year, do you smoke 
now", etc.): 11 out of 35 ex- 
smokers (as defined by the inter- 
view) had described themselves 
as non-smokers instead of ex- 
smokers in the short questionnaire. 
Prevalence of symptoms 
Questions on asthma ("have you 
had an attack of asthma within the 
last 12 months?"), wheezing apart 
from cold ("have you had wheezing 
or whistling in your chest at any 
time in the last 12 months when 
you did not have a cold?"), phlegm 
("do you usually bring up phlegm 
on most days for as much as 3 
months each year?") and allergic 
rhinitis ("do you have any nasal al- 
lergies including hay fever?") were 
asked in both the SAPALDIA 
interview questionnaire and in the 
mailed short questionnaire of the 
European Community Respiratory 
Health Survey sent to all non-parti- 
cipants. As the short questionnaire 
was filled in by 2244 of the 6616 
non-participants, it was possible to 
compare symptom prevalences in 
participants and non-participants. 
Table 9 shows the results of this 
comparison of the raw data. Com- 
pared to participants, non-partici- 
pants were less likely to report 
asthma, wheezing apart from cold 
and allergic rhinitis, but more like- 
ly to report phlegm. 
To account for the known influen- 
ces of age, sex and smoking status 
on symptom prevalence, logistic 
regression models were calculated 
controlling for these variables plus 
area, but the strength of the asso- 
ciations was essentially unchanged 
(Table 10). 
Using the logistic regression model 
described above, the strength and 
direction of the association was 
compared between centres by in- 
cluding centre-participation inter- 
action terms. The effects of partici- 
pation did not vary significantly at 
the 5 % level for asthma, wheezing 
nor phlegm. For allergic rhinitis 
however, the association with parti- 
cipation varied significantly across 
centres, resulting in odds ratios 
Table 9. Prevalence of symptoms in participants and non-participants of the SAPALDIA cross-sectional study. 
Information on symptoms was available through the mailed short questionnaire of the European Community 
Respiratory Health Survey for 31.8 % of the 6616 non-participants. Raw data. 
Table 10. Odds ratios for reporting symptoms in non-participants compared to participants. Logistic regression 
model controlling for age, sex, smoking status and area. For asthma, wheezing and phlegm there was no signifi- 
cant difference in the strength and direction of the association across centres, for allergic rhinitis the associations 
varied significantly with odds ratios ranging from 0.52 to 1.29 
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Switzerland residents 04.12.90, 18-60 years 
Female Male 
SAPALDIA participants , . : :  , ,  
Female Male 
Urban/suburban population 1 473911 1 508349 2600 2499 
71.3% 69.8% 53.0% 52.7% 
Rural ooDulation 593 918 651 693 2308 2244 
28.7 % 30.2 % 47.0 % 47.3 % 
Total 2 067 829 2160 042 4908 4743 
100% 100% 100% 100% 
Table 11. Urban~suburban nd rural population in Switzerland (18-60 years of age, Swiss Federa/ Office of Statis- 
tics, personal communication) and in the participants of the SAPALDIA cross-sectional study, Differences between 
genders are small, for both genders the proportion of the urban~suburban population is substantially smaller in the 
SAPALDIA participants. 
ranging from 0.52 in Aarau to 1.29 
in Geneva. 
Because some of the centres were 
known for their clean air or their 
respiratory medicine institutions, it 
was possible that some people 
might have moved there seeking 
help for their respiratory problems. 
Therefore from March 1991 on all 
participants were asked whether 
they had been living in the area 
since they were born, and if not, 
what were their reasons for moving 
there. In all centres less than 1% of 
the participants had moved to the 
area for health reasons with the 
exception of Davos, where this was 
the case for 34 (5.7 %) of the 596 
participants who answered the 
question. 21 (3.5%) of them re- 
ported having moved there because 
of asthma, 7 (1.2%) because of 
other respiratory diseases. The 
group of people having moved to 
Davos because of health problems 
represented 24 of the 54 partici- 
pants reporting doctor's diagnosed 
asthma (n = 597) and 14 of the 18 
participants reporting current asth- 
ma symptoms (n = 594). 
Degree of urbanisation 
The centres of the SAPALDIA 
study were chosen to represent the 
variety of environmental condi- 
tions found in Switzerland and not 
the varying patterns of urbanisa- 
tion throughout the country. By the 
end of 1990, more than two thirds 
of the residents of Switzerland 
were living in urban or suburban 
areas 24, while only the study cen- 
tres Geneva, Basle, Lugano and 
Aarau fit this description. Table 11 
shows the exact numbers for both 
the Switzerland residents of 18- 
60 years and the participants of the 
SAPALDIA cross-sectional study. 
Discussion 
To achieve the aims of the SAPAL- 
DIA study which are the assess- 
ment of the prevalence of bron- 
chial asthma, chronic bronchitis 
and allergic onditions in the adult 
population of Switzerland and the 
identification and the determina- 
tion of the respective importance 
of potentially influencing factors, 
two issues are of crucial importance: 
The standardisation f assessment 
techniques and the avoidance of 
any relevant selection bias. 
Standardisation fmethods 
To achieve asatisfying standardisa- 
tion of instruments, everal steps 
were taken. All methods of the 
health assessment were developed 
along with the questionnaire of the 
European Community Respiratory 
Health Survey and evaluated and 
validated in detail before the 
beginning of investigations. For the 
computerised SAPALDIA ques- 
tionnaire the preferential use of 
questions established in other 
questionnaires like the one of the 
MONICA study and a sophisticat- 
ed system of translation and cross- 
translation minimised linguistic dif- 
ferences in the German, French and 
Italian version. All study centres 
were run under the resposibility 
of a qualified respiratory physician 
with vast experience in lung func- 
tion testing and allergy skin testing. 
For endexpiratory CO-measure- 
ments a pilot study was under- 
taken before the beginning of the 
SAPALDIA study that confirmed 
the reliability of the method. 
A steering committee composed of 
members of the SAPALDIA team 
representing all disciplines involv- 
ed met monthly to follow the 
course of the study and to take care 
of general coordination, participa- 
tion and quality control. 
The fieldworkers, including ajunior 
physician in each centre, were 
extensively instructed and trained 
and were given detailed written 
instructions on all health assess- 
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ment techniques. Before the first 
SAPALDIA participant ever enter- 
ed a study centre, all techniques 
were practised on volunteers. 
After the beginning of investiga- 
tions the local teams were in close 
contact with both the local respon- 
sible respiratory physician and the 
central epidemiology unit of the 
study at the Institute of Social 
and Preventive Medicine in Basle. 
Apart from individual contacts 
through telephone and personal 
visits regular meetings were held, 
uniting the fieldworkers of the dif- 
ferent centres to discuss problems 
and give new instructions. Regular 
calibration of the instruments was 
performed for pulmonary function 
testing, methacholine challenge 
testing and endexpiratory CO mea- 
surements. A number of quality 
control measurements were intro- 
duced particularly on pulmonary 
function testing 17 and allergy skin 
testing to maintain a high level of 
quality. 
After the data collection period all 
spirometry outputs were visually 
screened by a junior physician with 
experience in lung function testing 
and a qualified respiratory physi- 
cian. Their judgement and critical 
remarks of the spirometry techni- 
cians were used as additional quali- 
ty standards to the established ATS 
criteria. As the decision about the 
inclusion or exclusion of spirometry 
curves and values was based on qua- 
lity criteria alone and not on the size 
of the outcome measurements, no
selection bias has to be expected. 
To rule out any possible effect of 
the changing of all nebulisers in 
spring 1991, the bronchial reactivi- 
ty data were checked for any dif- 
ferences before and after the ex- 
change or any time trend, but no 
such effects could be detected. 
Specific methods of standardisa- 
tion were applied for the environ- 
mental data assessment and devia- 
tions in accuracy could be quanti- 
fied. More information on this sub- 
ject can be found in a separate 
publication 21. 
Selection of participants 
To obtain a high participation in 
the random samples drawn from 
the local registries of inhabitants 
and to avoid any important selec- 
tion bias, different strategies were 
chosen to approach the partici- 
pants. The study was presented in 
the national media and local publi- 
city campaigns were organised by 
the local respiratory physicians 
when the sample was first contact- 
ed. Letters of invitation were 
written including information on 
the aims and the design of the study 
and people were invited to send 
back prepared postcards to con- 
firm their participation. If no post- 
card was returned, efforts were 
made to contact the individuals 
through repeated telephone calls, 
and if necessary personal visits 
were made to the homes of indi- 
viduals. So only 279 people, repre- 
senting 1.7 % of the total sample of 
16267, could not be reached. 
9651 individuals agreed to come to 
the study centres for the examina- 
tion of about 11/2 hours, represent- 
ing a participation rate of 59.3 % 
(Table 6). The relatively high differ- 
ences in participation between the 
study centres might be due to the 
different size, social structure and 
cultural background of the areas as 
well as to the differing promotional 
strategies applied locally. Looking 
at the completeness of the different 
tests (Table 7), all participants by 
definition had completed the 
computerised interview and more 
than 97 % had completed spirome- 
try, endexpiratory CO testing and 
allergy skin testing. Serological 
testing requiring the taking of a 
blood sample and bronchial chal- 
lenge testing requiring the inhala- 
tion of a potentially scaring chemi- 
cal agent were less complete with 
participation varying considerably 
across centres. 75.3 % of all partici- 
pants had a complete set of tests 
(Table 8), with a slightly higher ate 
in male (79.4%) than female par- 
ticipants (71.4%). As participants 
were informed about all tests in 
advance and were free not to take 
part in any of them, these differ- 
ences between centres and also 
between genders might be the 
expression of different ways of 
approaching and reassuring parti- 
cipants in addition to the reasons 
mentioned above. 
With a non-participation rate of 
40.7 % there is a potential for selec- 
tion bias. To quantify this potential 
additional information on non-par- 
ticipants was gained by telephone 
interviews during the first contact 
and by the mailed short question- 
naire of the European Respiratory 
Health Survey. Comparing non- 
participants to participants, an 
overrepresentation f the inter- 
mediate age group (30-44 years) 
could be seen in participants. The 
practical implications of this mode- 
rate distortion of the age structure 
are limited but point out the 
importance of presenting age stan- 
dardised prevalences and of con- 
trolling for age in modelling. The 
gender atio was practically identi- 
cal in participants, in non-partici- 
pants, and also in the general popu- 
lation of the study centres in the re- 
spective age group (18-60 years). 
For nationality, no information 
was available on non-participants. 
When comparing participants to 
the population of local residents 
for at least three years (data avail- 
able only for Basle), or particularly 
to the local population of 18-60 
years without any restriction on the 
time of residency, a clear underre- 
presentation of non-Swiss natio- 
nals could be seen. This might be 
due to the known limitations in 
efficiently involving foreign popu- 
lations in promotional activities 
targeted at the general population 
rather than at specific subgroups. 
Data on smoking status were avail- 
able for both participants and a 
good part of non-participants. As 
could be expected, the proportion 
of current smokers and also former 
smokers or ex-smokers was sub- 
stantially lower in females. Corn- 
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bining the information from the 
different sources, in participants 
of both genders the proportion of 
current smokers was about the 
same as in non-participants. Ex- 
smokers eemed to be moderate- 
ly overrepresented, therefore re- 
ducing the proportion of never- 
smokers. 
Non-response bias is known to be 
an important factor in epidemiolo- 
gical studies 25. A detailed investi- 
gation of the question in the 
SAPALDIA centre of Payerne 
showed a tendency of higher pre- 
valences of respiratory symptoms 
in participants compared to non- 
participants, though significant dif- 
ferences could be seen only for 
wheezing within the last 12 months 
(12.5 % in participants versus 5.6 % 
in non-participants) 26. The results 
in Tables 13 and 14 show the expec- 
ted overrepresentation of indivi- 
duals reporting asthma, wheezing, 
and allergic rhinitis in the partici- 
pants of the study. These differ- 
ences are smaller than the one 
seen for wheezing in the study in 
Payerne and could partly be due to 
oral explanations given during the 
SAPALDIA interview. The inverse 
relationship for phlegm is surpris- 
ing and could partly be explained 
by a greater reluctance of reporting 
a symptom perceived as disgusting 
to an interviewer inthe computeris- 
ed questionnaire as opposed to 
simply crossing an answer in the 
short questionnaire. This explana- 
tion is supported by observations 
made in the 185 participants who 
answered the respective questions 
in both the EC short questionnaire 
and the computerised SAPALDIA 
questionnaire: 9 of them reported 
phlegm in both questionnaires, 6 in 
the computerised questionnaire 
only and 19 in the short ques- 
tionnaire xclusively. 
As comparing prevalences across 
centres is a crucial issue of 
SAPALDIA, it is very reassuring 
to see that the observed selection 
bias is uniform across centres for 
asthma, wheezing and phlegm. For 
allergic rhinitis however, the asso- 
ciation varies widely. The German 
speaking centres (Aarau, Basle, 
Davos and Wald) seem to form one 
group with odds ratios ranging 
from 0.52 to 0.62 and the French 
speaking (Geneva, Payerne and 
Montana; OR 0.83-1.29) and 
Italian speaking (Lugano, OR 
0.96) centres a second group. The 
192 participants who answered the 
respective questions in both the 
EC short questionnaire and the 
computerised SAPALDIA ques- 
tionnaire show a slightly better -
though not significantly different - 
correspondence b tween the two 
questionnaires in the German 
speaking than in the non-German 
speaking centres and therefore 
support he idea of an intercultural 
difference. 
Slightly more than half of the 
SAPALDIA participants lived in a 
urban or suburban surrounding 
compared to about 70% of the 
residents of Switzerland of 18-60 
years (Table 11). This illustrates 
that the SAPALDIA centres were 
chosen to represent the different 
environmental conditions found in 
Switzerland and not the population 
of Switzerland as a whole. 
The restriction of the study base 
to the age group of 18 to 60 years 
had the objective to study effects 
in the working age segment of the 
population. The effects in children 
were addressed in the separate 
Swiss Study on Childhood Allergy 
and Respiratory Symptoms with 
Respect to Air Pollution and 
Climate SCARPOL 27. The ex- 
clusion of individuals who had 
been living in the area for less than 
three years was an attempt to 
improve long-term exposure classi- 
fication. 
The SAPALDIA participants re- 
present the adult permanent re- 
sidents of the study centres. The 
good representation f males and 
females and of both smokers and 
non-smokers give the possibility of 
coming to conclusions about these 
groups. The moderate distortion of 
the age structure will be accounted 
for by age-standardisation or con- 
trolling for age. The moderate 
overrepresentation of ex-smokers 
is irrelevant because analyses will 
either use stratification by or con- 
trolling for smoking status. The dif- 
ferences in reporting symptoms 
between participants and non- 
participants can be partly explain- 
ed by different questionnaire t ch- 
niques or intercultural differences. 
The relative importance of these 
effects should be determined 
by further investigation. The uni- 
formity of the selection effects 
between centres for respiratory 
symptoms indicates an acceptable 
comparability. 
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